SlideShare a Scribd company logo
Acute Exacerbation Chronic or long
term
•Severe
•Short term
•Also known as attack
•High doses are required
•Mild
•Long term
Suitable therapy:
Nebulisation
Suitable therapy:
MDI + Spacer/ DPI
Asthma
Presentation
Asthma
Acute Exacerbation
Exacerbations of asthma (asthma attacks or acute asthma) are
episodes of progressive increase in shortness of breath, cough,
wheezing, or chest tightness, or some combination of these
symptoms.
Severe exacerbations are potentially life threatening, and their
treatment requires close supervision.
Patients with severe exacerbations should be encouraged to
see their physician promptly or, to proceed to the nearest clinic
or hospital that provides emergency access for patients with
acute asthma.
GINA 2006
Asthma
Acute asthma
All patients with asthma
irrespective of their
severity; are at a risk of
developing an acute
attack…
Acute asthma Symptoms
• Increased Breathlessness / Dysponea
[Difficulty in breathing]
• Increased Wheezing
[Whistling sound while exhaling]
• Increased Cough
[Often at night or after some exertion]
• Chest Tightness
Acute Asthma Signs
• Inability to complete a sentence
• Tachycardia [rapid heart beats]
• Tachypnea [rapid breathing]
• Accessory respiratory muscle use [around neck]
• Excessive sweating
• Cyanosis [blue discoloration of skin, lips in acute
severe cases]
Who is at risk?
• Previous hospitalization or “casualty visit” for asthma in
past year
• Currently using or have recently stopped using oral
steroids
• Not currently using preventive therapy
• Frequent use of salbutamol /terbutaline
• Emotional/ psychological component of asthma.
These patients require closer attention and
should be encouraged to seek urgent care
early in the course of their attacks.
Symptoms Mild- Moderate Severe- life threatening
Breathless On walking or talking At rest
Talks in Sentences / Phrases Words/
Unable to speak
Accessory muscles Usually not Usually
Central Cyanosis Absent Likely to be present
SaO2
[as measured by pulse
oximeter]
91-95%
OR
> 95%
< 90%
Pulse
rate
Adults <100-120 / min > 120 / min
Children <100-200 / min > 200 / min
Acute asthma classification
Refer to hospital
any patient with
features of
acute severe to life
threatening asthma
Routes of administration of
anti-asthma drugs
Oral Inhaled Parenteral
Tablets
Syrup
Metered dose inhaler (MDI)
Dry powder inhaler (DPI)
Injections
Nebulizers
Nebulizer
Delivers a therapeutic dose
of the drug as an aerosol in
the form of respirable
particles within a short
period, 5-10 mins.
Why nebulized therapy.......
• Immediate relief is required which can be achieved only from
inhalation therapy.
• Targeted drug delivery.
• Easy to Use
• When High dose of medications are required.
• Does not require coordination between inspiration and actuation as
it uses normal tidal breathing.
• Patient who does not respond to regular treatment with oral or other
inhaled devices, may benefit.
• Critically ill patients, unable to co-ordinate with other inhaler
devices like MDI or Rotahaler , may benefit.
• Profitable
Advantages of nebulized therapy
Over Injectables
Targeted drug delivery
Lesser side effects
Non invasive / Painless
Easy to use
Over Orals
Targeted drug delivery
Lesser side effects
Faster onset of action
Very useful in acute cases
Nebulized therapy used for…
• Acute attacks of asthma
• Acute attacks of COPD
• Symptomatic relief of Croup
• Other respiratory diseases presenting with acute
bronchitis
• Rarely, at home, in mild-moderate acute asthma when
the patient can’t use other inhaler devices.
• Infants, children and elderly patients who can’t use other
inhaler devices.
Types of nebulizers
• JET Nebulizer
• Ultrasonic Nebulizer
JET nebulizer
• Based on compressed air technology.
• Widely used
• Economical
• Any form of liquid can be nebulized (including
suspensions).
Ultrasonic Nebulizer
• Based on high frequency sound waves technology.
• Finest mist and better deposition
• Not preferable for suspensions.
• Less noisy
• Costly, thus limits its use.
Parts of the Nebulizer
Nebulizer system consists of the following parts.
Tubing nebulization
Chamber
Mask/Mouthpiece
Compressor
• The compressor is the portable pump which provides power
for nebulizer.
• The nebulizer is the small chamber into which the liquid
medicine is put and through which the air is blown to make a
mist.
Important Aspects
Fill Volumes
• Ideal volume of the drug
to be put in the
nebulization chamber is
usually 2-4 ml
Important Aspects
Nebulization Time
• Time from starting
nebulization until
continuous nebulization
has ceased
• For bronchodilators it
should be <10 mins.
Important Aspects
Nebulization End point
• Patients should be
nebulize for about a
minute after ‘spluttering’
occurs
• Residual volume of 0.5 to
1 ml will always remain in
the nebulizer
Important Aspects
Driving gas flow rate
• Most jet nebulizers work
at a flow rate of 6-8 l/min
• Oxygen can be used if a
compressor is not
available.
Important Aspects
Breathing pattern of patient
• Steady normal breathing
• Occasional deep breath
Important Aspects
OR
Face Masks Mouthpiece
Prefer When Patient is …
•Too critical
•Unconscious
•Pediatric
Prefer When Patient is …
• Comfortable enough to hold the
mouthpiece
• Receiving anticholinergics
• Receiving Steroids
Do not talk while being nebulized
Management of mild / moderate
acute asthma
After brief history* and physical
examination…
*Rule out beta blocker or NSAID [aspirin] use, check for exposure
to strong trigger
Rapid Acting Bronchodilators
• Repeated administration of rapid-acting inhaled beta2-
agonists.
E.g. Salbutamol or Levosalbutamol respules /MDI
• Every 20 min for first 3 doses
• After the first hour, the dose of beta2-agonist required will
depend on the severity of the exacerbation.
Rapid Acting Bronchodilators
• Treatment should also be titrated depending upon the
individual patient response.
• No evidence to support the routine use of IV beta2
agonists.
NEBULIZED [Respules/
Respirator solution]
MDI + SPACER
Salbutamol
[Asthalin]
Adult 2.5-5 mg Adult 8-12 puffs per hour
Child 1.25 -2.5 mg Child 4-6 puffs per hour
Levosalbutamol
[Levolin]
Adult 0.63-1.25 mg Adult 4-6 puffs per hour
Child 0.31-0.63 mg Child 2-3 puffs per hour
• Many patients will be able to monitor their PEF after the
initiation of increased bronchodilator therapy.
• No additional medication is necessary if the rapid-acting
inhaled beta2-agonist produces a complete response
(PEF returns to greater than 80% of predicted or
personal best) and the response lasts for 3 to 4 hours.
Rapid Acting Bronchodilators
Additional bronchodilators
• In case of poor response to beta2 agonist therapy; add
nebulized ipratropium bromide.
• Available In Combination As Duolin Respules
• Ipratropium +beta2 agonist combination:
– Greater bronchodialation
– Shorter duration of admission
– Faster recovery
Bronchodilators Adults Children
Ipratropium 250 – 500 mcg 250 mcg
Duolin LD
The Dual Action Bronchodilator
Brand Composition Pack
Duolin Respules Levosalbutamol 0.63 mg + Ipratropium bromide
500 mcg/ 2.5 ml
2.5 ml
Brand Volume of solution Dosage - adults and adolescents (above
12 years of age)
Duolin Respules 1 Respule 1 respule 3-4 times a day
If patient has…
• Reduced distress
• Able to complete sentence
• Near normal Pulse rate/ respiratory rate
• No use of accessory muscles
• Improved Oxygen saturation
[>95%=Child / >90%=Adult]
Consider sending home
Steroids in acute asthma
CHRONIC INFLAMMATION
Time
ACUTE
INFLAMMATION
Structural changes Airway
remodeling
What happens in acute asthma?
When?
• Initial bronchodilator therapy fails improvement
• Attack in patient already on oral steroids.
• Previous attacks required oral steroids.
Systemic Steroids
GINA 2008
Age Daily dose of prednisolone Treatment up to
<2 years 10 mg 3 days or until recovery
2-5 years 20 mg 3 days or until recovery
>5 years 30-40 mg 3 days or until recovery
adults 40-50 mg at least 5-7 days/until recovery
Budecort
Nebulised Steroid control in Difficult Asthma
Brand Composition Pack
Budecort
0.5 mg Respules
Budesonide 0.5 mg/2 ml 2 ml
Budecort
1 mg Respules
Budesonide 1 mg/2 ml 2 ml
Brand Dosage Adults Dosage Children
Budecort
0.5 mg
Respules
Initiating dose: 1-2 mg
twice daily
Maintenance dose:
0.5 mg –1 mg twice
daily
Initiating dose:
0.5-1 mg twice daily
Maintenance dose:
0.25 – 0.5mg twice
daily
Budecort
1 mg Respules
Combination of Bronchodilator &
Steroid
• Makes available both bronchodilator and steroids
• Targets different aspects of asthma, salbutamol
reverses the bronchoconstriction and budesonide
takes care of inflammation
• Reduces nebulisation time.
Budesal: (Salbutamol + Budesonide)
Budesal
The First Anti inflammatory corticosteroid +
Bronchodilator Nebulised Therapy
The First Anti inflammatory
corticosteroid + Bronchodilator
Nebulised Therapy
Brand Composition Pack
Budesal 0.5 mg Respules Salbutamol 2.5 mg +
Budesonide 0.5 mg
2.5 ml
Budesal 1 mg Respules Salbutamol 2.5 mg +
Budesonide 1 mg
2.5 ml
Brand Volume of
solution
Dosage Adults Dosage
Children
Budesal
0.5 mg
Respules
1-2
respules
1-2 respules(1
mg) twice daily
or 1 respule
thrice daily
1-2 respules(0.5
mg) twice daily
or 1 respule
thrice daily
Budesal 1 mg
Respules
1-2
respules
High dose rapid acting bronchodilator*
Salbutamol (Asthalin)/ levosalbutamol (Levolin)
Partial / no response…
Add ipratropium
In severe cases, one can directly start with duolin
Partial / no response…
Initiate Steroid therapy
Further treatment depends on severity of acute asthma & response to the initial treatment.
Summary so far…
If patient has…
• No distress
• Able to complete sentence
• Near normal Pulse rate/ respiratory rate
• No use of accessory muscles
• Oxygen saturation [>95%=Child / >90%=Adult]
• Improved lung function [greater than 80% of predicted or
personal best]
Consider sending home
If patient has…
• Poor Response to Therapy
• Severe symptoms
• Drowsiness
• Cyanosis
• Also if already, High Risk Patient
Refer to hospital / ICU….
Other bronchodilators…
Theophylline
• Much less effective than Salbutamol + Ipratropium
• Injectible should be used in hospital settings only, with
monitoring serum levels.
• Mainly used as an add on therapy for prevention.
[long acting oral preparation]
Adrenaline
• Not routinely indicated for asthma attacks; mainly
indicated for anaphylaxis.
Do’s
• Never delay transfer to hospital/ICU if necessary
• Try to check pulse oximeter saturations at every step
• Ensure the patient who has been hospitalized is
discharged with regular ICS.
• Ensure patient has written asthma action plan.
• Prevent future acute asthma attacks by prescribing
regular treatment with inhaled corticosteroid
[MDI/ DPI].
The story of asthma treatment
Traditional treatment
Occasional Relievers
Ideal treatment
Regular Controllers
i.e. ICS
Follow up after hospital discharge
• Review within 48 hours
• Monitor symptoms and PEF
• Check inhaler technique
• Modify treatment according to severity
• Follow up with chest physician at regular interval
Good Nebulizer practice: Cleaning
• Disassemble.
• Wash in warm water with detergent at least once a day.
• Carefully dry.
• The nebulizer should be run empty for a moment or two
before the next use.
Respule
• A “respule” is an ampoule containing the liquid drug to
be nebulized.
• It contains drug, which is prediluted and hence can be
used directly.
• The respule should be broken and the liquid drug
should be pored into the nebulization chamber.
• Respules are for inhalation use only.
• The solution should not be injected or swallowed.
Respirator Solution
• Respirator solution contains the drug to be nebulized in
concentrated form.
• Dilute the drug concentrate in a ratio of 1 part of drug
solution: 3 parts of normal saline (0.9% sodium chloride).
• Care should be taken that after diluting the fill volume
should not exceed of 2-4 ml.
• It is not recommended to use distilled water or tap water
contains certain elements which itself could irritate the
airways.
A diagnosed asthmatic
breathless patient
comes to your clinic ……
What would be your line of treatment ?????

More Related Content

Similar to Acute Asthma PPT.ppt

ANTI-ASTHMATICS
ANTI-ASTHMATICSANTI-ASTHMATICS
ANTI-ASTHMATICS
devi pothina
 
management of asthma
management of  asthmamanagement of  asthma
management of asthma
Theja Huruggamuwa
 
Management of Asthma at Primary Care Level
Management of Asthma at Primary Care LevelManagement of Asthma at Primary Care Level
Management of Asthma at Primary Care Level
Redzwan Abdullah
 
Gnp and home nebulization
Gnp and home nebulizationGnp and home nebulization
Gnp and home nebulization
drsubhadip
 
Acute severe Asthma case presentation
Acute severe Asthma case presentationAcute severe Asthma case presentation
Acute severe Asthma case presentation
Dr.Rania Ismail Deeb Elashker
 
COPD.pptx
COPD.pptxCOPD.pptx
Pediatric Asthma Exacerbation Management
Pediatric Asthma Exacerbation ManagementPediatric Asthma Exacerbation Management
Pediatric Asthma Exacerbation Management
Fatima Farid
 
OTC Medications - Cough
OTC Medications - CoughOTC Medications - Cough
OTC Medications - Cough
Areej Abu Hanieh
 
2
22
Asthma devices.pptx
Asthma devices.pptxAsthma devices.pptx
Asthma devices.pptx
Dr Debasish Mohapatra
 
Antifungals, Quality of Life study and Inhalers
Antifungals, Quality of Life study and InhalersAntifungals, Quality of Life study and Inhalers
Antifungals, Quality of Life study and Inhalers
Graham Atherton
 
Agents used for sedation in pediatric dentistry
Agents used for sedation in pediatric dentistry Agents used for sedation in pediatric dentistry
Agents used for sedation in pediatric dentistry
Aya Adel
 
Premedicant drugs in Anesthesia
Premedicant drugs in AnesthesiaPremedicant drugs in Anesthesia
Premedicant drugs in Anesthesia
Vaishali Syal
 
Management of copd by DR TASLEEM ARIF
Management of copd by DR TASLEEM ARIFManagement of copd by DR TASLEEM ARIF
Management of copd by DR TASLEEM ARIF
TASLEEM ARIF
 
Drugs related to respiratory system
Drugs related to respiratory systemDrugs related to respiratory system
Drugs related to respiratory system
anaesthesiaESICMCH
 
CITIZEN Nebulizer Segment
CITIZEN Nebulizer SegmentCITIZEN Nebulizer Segment
CITIZEN Nebulizer Segment
Laila C. Erut Morinigo - Island Gate LLC
 
Inhaler therapy
Inhaler therapyInhaler therapy
Acute exacerbation of asthma
Acute exacerbation of asthmaAcute exacerbation of asthma
Acute exacerbation of asthma
Silah Aysha
 
bronchial asthma.ppt
bronchial asthma.pptbronchial asthma.ppt
bronchial asthma.ppt
PreetiSharma428161
 
Asthma management RAJEEV BAHALL
Asthma management RAJEEV BAHALLAsthma management RAJEEV BAHALL
Asthma management RAJEEV BAHALL
Rajeev Bahall
 

Similar to Acute Asthma PPT.ppt (20)

ANTI-ASTHMATICS
ANTI-ASTHMATICSANTI-ASTHMATICS
ANTI-ASTHMATICS
 
management of asthma
management of  asthmamanagement of  asthma
management of asthma
 
Management of Asthma at Primary Care Level
Management of Asthma at Primary Care LevelManagement of Asthma at Primary Care Level
Management of Asthma at Primary Care Level
 
Gnp and home nebulization
Gnp and home nebulizationGnp and home nebulization
Gnp and home nebulization
 
Acute severe Asthma case presentation
Acute severe Asthma case presentationAcute severe Asthma case presentation
Acute severe Asthma case presentation
 
COPD.pptx
COPD.pptxCOPD.pptx
COPD.pptx
 
Pediatric Asthma Exacerbation Management
Pediatric Asthma Exacerbation ManagementPediatric Asthma Exacerbation Management
Pediatric Asthma Exacerbation Management
 
OTC Medications - Cough
OTC Medications - CoughOTC Medications - Cough
OTC Medications - Cough
 
2
22
2
 
Asthma devices.pptx
Asthma devices.pptxAsthma devices.pptx
Asthma devices.pptx
 
Antifungals, Quality of Life study and Inhalers
Antifungals, Quality of Life study and InhalersAntifungals, Quality of Life study and Inhalers
Antifungals, Quality of Life study and Inhalers
 
Agents used for sedation in pediatric dentistry
Agents used for sedation in pediatric dentistry Agents used for sedation in pediatric dentistry
Agents used for sedation in pediatric dentistry
 
Premedicant drugs in Anesthesia
Premedicant drugs in AnesthesiaPremedicant drugs in Anesthesia
Premedicant drugs in Anesthesia
 
Management of copd by DR TASLEEM ARIF
Management of copd by DR TASLEEM ARIFManagement of copd by DR TASLEEM ARIF
Management of copd by DR TASLEEM ARIF
 
Drugs related to respiratory system
Drugs related to respiratory systemDrugs related to respiratory system
Drugs related to respiratory system
 
CITIZEN Nebulizer Segment
CITIZEN Nebulizer SegmentCITIZEN Nebulizer Segment
CITIZEN Nebulizer Segment
 
Inhaler therapy
Inhaler therapyInhaler therapy
Inhaler therapy
 
Acute exacerbation of asthma
Acute exacerbation of asthmaAcute exacerbation of asthma
Acute exacerbation of asthma
 
bronchial asthma.ppt
bronchial asthma.pptbronchial asthma.ppt
bronchial asthma.ppt
 
Asthma management RAJEEV BAHALL
Asthma management RAJEEV BAHALLAsthma management RAJEEV BAHALL
Asthma management RAJEEV BAHALL
 

More from PankajSharma956210

PATHOGENESIS_OF_BACTERIAL_INFECTION.pdf
PATHOGENESIS_OF_BACTERIAL_INFECTION.pdfPATHOGENESIS_OF_BACTERIAL_INFECTION.pdf
PATHOGENESIS_OF_BACTERIAL_INFECTION.pdf
PankajSharma956210
 
Antibiotics (5).ppt
Antibiotics (5).pptAntibiotics (5).ppt
Antibiotics (5).ppt
PankajSharma956210
 
benefit and scope of asthma.pdf
benefit and scope of asthma.pdfbenefit and scope of asthma.pdf
benefit and scope of asthma.pdf
PankajSharma956210
 
2.3.10 Sohal Interstitial Lung Disease.ppt
2.3.10 Sohal Interstitial Lung Disease.ppt2.3.10 Sohal Interstitial Lung Disease.ppt
2.3.10 Sohal Interstitial Lung Disease.ppt
PankajSharma956210
 
2infectious-diseases.ppt
2infectious-diseases.ppt2infectious-diseases.ppt
2infectious-diseases.ppt
PankajSharma956210
 
Antifungal drugs_E.ppt
Antifungal drugs_E.pptAntifungal drugs_E.ppt
Antifungal drugs_E.ppt
PankajSharma956210
 
GNP.pptx
GNP.pptxGNP.pptx
Asthma_In_General_Practice_dec_2010.ppt
Asthma_In_General_Practice_dec_2010.pptAsthma_In_General_Practice_dec_2010.ppt
Asthma_In_General_Practice_dec_2010.ppt
PankajSharma956210
 

More from PankajSharma956210 (8)

PATHOGENESIS_OF_BACTERIAL_INFECTION.pdf
PATHOGENESIS_OF_BACTERIAL_INFECTION.pdfPATHOGENESIS_OF_BACTERIAL_INFECTION.pdf
PATHOGENESIS_OF_BACTERIAL_INFECTION.pdf
 
Antibiotics (5).ppt
Antibiotics (5).pptAntibiotics (5).ppt
Antibiotics (5).ppt
 
benefit and scope of asthma.pdf
benefit and scope of asthma.pdfbenefit and scope of asthma.pdf
benefit and scope of asthma.pdf
 
2.3.10 Sohal Interstitial Lung Disease.ppt
2.3.10 Sohal Interstitial Lung Disease.ppt2.3.10 Sohal Interstitial Lung Disease.ppt
2.3.10 Sohal Interstitial Lung Disease.ppt
 
2infectious-diseases.ppt
2infectious-diseases.ppt2infectious-diseases.ppt
2infectious-diseases.ppt
 
Antifungal drugs_E.ppt
Antifungal drugs_E.pptAntifungal drugs_E.ppt
Antifungal drugs_E.ppt
 
GNP.pptx
GNP.pptxGNP.pptx
GNP.pptx
 
Asthma_In_General_Practice_dec_2010.ppt
Asthma_In_General_Practice_dec_2010.pptAsthma_In_General_Practice_dec_2010.ppt
Asthma_In_General_Practice_dec_2010.ppt
 

Recently uploaded

Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
walterHu5
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
Dhayanithi C
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
HongBiThi1
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
reignlana06
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
suvadeepdas911
 
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Kosmoderma Academy Of Aesthetic Medicine
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
rishi2789
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
PsychoTech Services
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
rishi2789
 
Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024
Torstein Dalen-Lorentsen
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
Josep Vidal-Alaball
 
pathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathologypathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathology
ZayedKhan38
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
DECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principlesDECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principles
anaghabharat01
 
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
FFragrant
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
rishi2789
 
Acute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdfAcute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdf
Jim Jacob Roy
 

Recently uploaded (20)

Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
 
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
 
Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
 
pathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathologypathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathology
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
DECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principlesDECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principles
 
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
 
Acute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdfAcute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdf
 

Acute Asthma PPT.ppt

  • 1. Acute Exacerbation Chronic or long term •Severe •Short term •Also known as attack •High doses are required •Mild •Long term Suitable therapy: Nebulisation Suitable therapy: MDI + Spacer/ DPI Asthma Presentation Asthma
  • 2. Acute Exacerbation Exacerbations of asthma (asthma attacks or acute asthma) are episodes of progressive increase in shortness of breath, cough, wheezing, or chest tightness, or some combination of these symptoms. Severe exacerbations are potentially life threatening, and their treatment requires close supervision. Patients with severe exacerbations should be encouraged to see their physician promptly or, to proceed to the nearest clinic or hospital that provides emergency access for patients with acute asthma. GINA 2006 Asthma
  • 3. Acute asthma All patients with asthma irrespective of their severity; are at a risk of developing an acute attack…
  • 4. Acute asthma Symptoms • Increased Breathlessness / Dysponea [Difficulty in breathing] • Increased Wheezing [Whistling sound while exhaling] • Increased Cough [Often at night or after some exertion] • Chest Tightness
  • 5. Acute Asthma Signs • Inability to complete a sentence • Tachycardia [rapid heart beats] • Tachypnea [rapid breathing] • Accessory respiratory muscle use [around neck] • Excessive sweating • Cyanosis [blue discoloration of skin, lips in acute severe cases]
  • 6. Who is at risk? • Previous hospitalization or “casualty visit” for asthma in past year • Currently using or have recently stopped using oral steroids • Not currently using preventive therapy • Frequent use of salbutamol /terbutaline • Emotional/ psychological component of asthma. These patients require closer attention and should be encouraged to seek urgent care early in the course of their attacks.
  • 7. Symptoms Mild- Moderate Severe- life threatening Breathless On walking or talking At rest Talks in Sentences / Phrases Words/ Unable to speak Accessory muscles Usually not Usually Central Cyanosis Absent Likely to be present SaO2 [as measured by pulse oximeter] 91-95% OR > 95% < 90% Pulse rate Adults <100-120 / min > 120 / min Children <100-200 / min > 200 / min Acute asthma classification Refer to hospital any patient with features of acute severe to life threatening asthma
  • 8. Routes of administration of anti-asthma drugs Oral Inhaled Parenteral Tablets Syrup Metered dose inhaler (MDI) Dry powder inhaler (DPI) Injections Nebulizers
  • 9. Nebulizer Delivers a therapeutic dose of the drug as an aerosol in the form of respirable particles within a short period, 5-10 mins.
  • 10. Why nebulized therapy....... • Immediate relief is required which can be achieved only from inhalation therapy. • Targeted drug delivery. • Easy to Use • When High dose of medications are required. • Does not require coordination between inspiration and actuation as it uses normal tidal breathing. • Patient who does not respond to regular treatment with oral or other inhaled devices, may benefit. • Critically ill patients, unable to co-ordinate with other inhaler devices like MDI or Rotahaler , may benefit. • Profitable
  • 11. Advantages of nebulized therapy Over Injectables Targeted drug delivery Lesser side effects Non invasive / Painless Easy to use Over Orals Targeted drug delivery Lesser side effects Faster onset of action Very useful in acute cases
  • 12. Nebulized therapy used for… • Acute attacks of asthma • Acute attacks of COPD • Symptomatic relief of Croup • Other respiratory diseases presenting with acute bronchitis • Rarely, at home, in mild-moderate acute asthma when the patient can’t use other inhaler devices. • Infants, children and elderly patients who can’t use other inhaler devices.
  • 13. Types of nebulizers • JET Nebulizer • Ultrasonic Nebulizer
  • 14. JET nebulizer • Based on compressed air technology. • Widely used • Economical • Any form of liquid can be nebulized (including suspensions).
  • 15. Ultrasonic Nebulizer • Based on high frequency sound waves technology. • Finest mist and better deposition • Not preferable for suspensions. • Less noisy • Costly, thus limits its use.
  • 16. Parts of the Nebulizer Nebulizer system consists of the following parts. Tubing nebulization Chamber Mask/Mouthpiece Compressor • The compressor is the portable pump which provides power for nebulizer. • The nebulizer is the small chamber into which the liquid medicine is put and through which the air is blown to make a mist.
  • 17. Important Aspects Fill Volumes • Ideal volume of the drug to be put in the nebulization chamber is usually 2-4 ml
  • 18. Important Aspects Nebulization Time • Time from starting nebulization until continuous nebulization has ceased • For bronchodilators it should be <10 mins.
  • 19. Important Aspects Nebulization End point • Patients should be nebulize for about a minute after ‘spluttering’ occurs • Residual volume of 0.5 to 1 ml will always remain in the nebulizer
  • 20. Important Aspects Driving gas flow rate • Most jet nebulizers work at a flow rate of 6-8 l/min • Oxygen can be used if a compressor is not available.
  • 21. Important Aspects Breathing pattern of patient • Steady normal breathing • Occasional deep breath
  • 22. Important Aspects OR Face Masks Mouthpiece Prefer When Patient is … •Too critical •Unconscious •Pediatric Prefer When Patient is … • Comfortable enough to hold the mouthpiece • Receiving anticholinergics • Receiving Steroids Do not talk while being nebulized
  • 23. Management of mild / moderate acute asthma After brief history* and physical examination… *Rule out beta blocker or NSAID [aspirin] use, check for exposure to strong trigger
  • 24. Rapid Acting Bronchodilators • Repeated administration of rapid-acting inhaled beta2- agonists. E.g. Salbutamol or Levosalbutamol respules /MDI • Every 20 min for first 3 doses • After the first hour, the dose of beta2-agonist required will depend on the severity of the exacerbation.
  • 25. Rapid Acting Bronchodilators • Treatment should also be titrated depending upon the individual patient response. • No evidence to support the routine use of IV beta2 agonists. NEBULIZED [Respules/ Respirator solution] MDI + SPACER Salbutamol [Asthalin] Adult 2.5-5 mg Adult 8-12 puffs per hour Child 1.25 -2.5 mg Child 4-6 puffs per hour Levosalbutamol [Levolin] Adult 0.63-1.25 mg Adult 4-6 puffs per hour Child 0.31-0.63 mg Child 2-3 puffs per hour
  • 26. • Many patients will be able to monitor their PEF after the initiation of increased bronchodilator therapy. • No additional medication is necessary if the rapid-acting inhaled beta2-agonist produces a complete response (PEF returns to greater than 80% of predicted or personal best) and the response lasts for 3 to 4 hours. Rapid Acting Bronchodilators
  • 27. Additional bronchodilators • In case of poor response to beta2 agonist therapy; add nebulized ipratropium bromide. • Available In Combination As Duolin Respules • Ipratropium +beta2 agonist combination: – Greater bronchodialation – Shorter duration of admission – Faster recovery Bronchodilators Adults Children Ipratropium 250 – 500 mcg 250 mcg
  • 28. Duolin LD The Dual Action Bronchodilator Brand Composition Pack Duolin Respules Levosalbutamol 0.63 mg + Ipratropium bromide 500 mcg/ 2.5 ml 2.5 ml Brand Volume of solution Dosage - adults and adolescents (above 12 years of age) Duolin Respules 1 Respule 1 respule 3-4 times a day
  • 29. If patient has… • Reduced distress • Able to complete sentence • Near normal Pulse rate/ respiratory rate • No use of accessory muscles • Improved Oxygen saturation [>95%=Child / >90%=Adult] Consider sending home
  • 31. CHRONIC INFLAMMATION Time ACUTE INFLAMMATION Structural changes Airway remodeling What happens in acute asthma?
  • 32. When? • Initial bronchodilator therapy fails improvement • Attack in patient already on oral steroids. • Previous attacks required oral steroids. Systemic Steroids GINA 2008 Age Daily dose of prednisolone Treatment up to <2 years 10 mg 3 days or until recovery 2-5 years 20 mg 3 days or until recovery >5 years 30-40 mg 3 days or until recovery adults 40-50 mg at least 5-7 days/until recovery
  • 33. Budecort Nebulised Steroid control in Difficult Asthma
  • 34. Brand Composition Pack Budecort 0.5 mg Respules Budesonide 0.5 mg/2 ml 2 ml Budecort 1 mg Respules Budesonide 1 mg/2 ml 2 ml Brand Dosage Adults Dosage Children Budecort 0.5 mg Respules Initiating dose: 1-2 mg twice daily Maintenance dose: 0.5 mg –1 mg twice daily Initiating dose: 0.5-1 mg twice daily Maintenance dose: 0.25 – 0.5mg twice daily Budecort 1 mg Respules
  • 35. Combination of Bronchodilator & Steroid • Makes available both bronchodilator and steroids • Targets different aspects of asthma, salbutamol reverses the bronchoconstriction and budesonide takes care of inflammation • Reduces nebulisation time. Budesal: (Salbutamol + Budesonide)
  • 36. Budesal The First Anti inflammatory corticosteroid + Bronchodilator Nebulised Therapy
  • 37. The First Anti inflammatory corticosteroid + Bronchodilator Nebulised Therapy Brand Composition Pack Budesal 0.5 mg Respules Salbutamol 2.5 mg + Budesonide 0.5 mg 2.5 ml Budesal 1 mg Respules Salbutamol 2.5 mg + Budesonide 1 mg 2.5 ml Brand Volume of solution Dosage Adults Dosage Children Budesal 0.5 mg Respules 1-2 respules 1-2 respules(1 mg) twice daily or 1 respule thrice daily 1-2 respules(0.5 mg) twice daily or 1 respule thrice daily Budesal 1 mg Respules 1-2 respules
  • 38. High dose rapid acting bronchodilator* Salbutamol (Asthalin)/ levosalbutamol (Levolin) Partial / no response… Add ipratropium In severe cases, one can directly start with duolin Partial / no response… Initiate Steroid therapy Further treatment depends on severity of acute asthma & response to the initial treatment. Summary so far…
  • 39. If patient has… • No distress • Able to complete sentence • Near normal Pulse rate/ respiratory rate • No use of accessory muscles • Oxygen saturation [>95%=Child / >90%=Adult] • Improved lung function [greater than 80% of predicted or personal best] Consider sending home
  • 40. If patient has… • Poor Response to Therapy • Severe symptoms • Drowsiness • Cyanosis • Also if already, High Risk Patient Refer to hospital / ICU….
  • 41. Other bronchodilators… Theophylline • Much less effective than Salbutamol + Ipratropium • Injectible should be used in hospital settings only, with monitoring serum levels. • Mainly used as an add on therapy for prevention. [long acting oral preparation] Adrenaline • Not routinely indicated for asthma attacks; mainly indicated for anaphylaxis.
  • 42. Do’s • Never delay transfer to hospital/ICU if necessary • Try to check pulse oximeter saturations at every step • Ensure the patient who has been hospitalized is discharged with regular ICS. • Ensure patient has written asthma action plan. • Prevent future acute asthma attacks by prescribing regular treatment with inhaled corticosteroid [MDI/ DPI].
  • 43. The story of asthma treatment Traditional treatment Occasional Relievers Ideal treatment Regular Controllers i.e. ICS
  • 44. Follow up after hospital discharge • Review within 48 hours • Monitor symptoms and PEF • Check inhaler technique • Modify treatment according to severity • Follow up with chest physician at regular interval
  • 45. Good Nebulizer practice: Cleaning • Disassemble. • Wash in warm water with detergent at least once a day. • Carefully dry. • The nebulizer should be run empty for a moment or two before the next use.
  • 46. Respule • A “respule” is an ampoule containing the liquid drug to be nebulized. • It contains drug, which is prediluted and hence can be used directly. • The respule should be broken and the liquid drug should be pored into the nebulization chamber. • Respules are for inhalation use only. • The solution should not be injected or swallowed.
  • 47. Respirator Solution • Respirator solution contains the drug to be nebulized in concentrated form. • Dilute the drug concentrate in a ratio of 1 part of drug solution: 3 parts of normal saline (0.9% sodium chloride). • Care should be taken that after diluting the fill volume should not exceed of 2-4 ml. • It is not recommended to use distilled water or tap water contains certain elements which itself could irritate the airways.
  • 48. A diagnosed asthmatic breathless patient comes to your clinic …… What would be your line of treatment ?????